Compugen (CGEN) Retained Earnings (2009 - 2025)
Compugen (CGEN) reported Retained Earnings of $8000.0 for Q4 2025, down 27.27% on a YoY basis from $11000.0 in Q4 2024, and up 100.0% sequentially from -$503.3 million in Q2 2025.
Compugen (CGEN) Retained Earnings (2009 - 2025) Analysis & Trends
Compugen (CGEN) has 17 years of Retained Earnings data on file, last reported at $8000.0 in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 27.27% year-over-year to $8000.0; the trailing twelve-month figure through Dec 2025 stood at $8000.0 (down 27.27% YoY), and the FY2025 full-year result was $8000.0, down 27.27% from the prior year.
- Retained Earnings grew to $8000.0 in Q4 2025, from -$503.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $11000.0 in Q4 2024 to a low of -$503.3 million in Q2 2025.
- A 5-year average of -$356.3 million and a median of -$440.9 million in 2022 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings jumped 100.0% in 2024 and decreased 27.27% in 2025, its largest moves.
- Tracing CGEN's Retained Earnings over 5 years: stood at -$422.1 million in 2021, then fell by 4.47% to -$440.9 million in 2022, then decreased by 7.62% to -$474.5 million in 2023, then jumped by 100.0% to $11000.0 in 2024, then declined by 27.27% to $8000.0 in 2025.
- Business Quant data shows CGEN's Retained Earnings at $8000.0 in Q4 2025, -$503.3 million in Q2 2025, and $11000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8,000.00 |
| Jun 30, 2025 | -503.28 Mn |
| Dec 31, 2024 | 11,000.00 |
| Jun 30, 2024 | -483.92 Mn |
| Dec 31, 2023 | -474.53 Mn |
| Jun 30, 2023 | -474.39 Mn |
| Jun 30, 2022 | -440.93 Mn |
| Dec 31, 2021 | -422.08 Mn |
| Jun 30, 2021 | -407.28 Mn |
| Dec 31, 2020 | -387.88 Mn |
| Jun 30, 2020 | -371.55 Mn |
| Dec 31, 2019 | -358.18 Mn |
| Jun 30, 2019 | -345.23 Mn |
| Dec 31, 2018 | -330.84 Mn |
| Jun 30, 2018 | -318.33 Mn |
| Dec 31, 2017 | -308.24 Mn |
| Jun 30, 2017 | -289.06 Mn |
| Dec 31, 2016 | -270.97 Mn |
| Jun 30, 2016 | -254.69 Mn |
| Dec 31, 2015 | -239.46 Mn |